Home › Funds › Point72 Asset Management › RLAY
Point72 Asset Management position in RLAY
RELAY THERAPEUTICS INC · Health Care
Latest position (Q4 2025)13.86M sh
Reported value held$117.25M
Portfolio Weight0.14%
First reportedQ2 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2023 | 276.54K | $3.47M | New |
| Q3 2023 | 20.21K | $170.01K | Reduce |
| Q1 2024 | 952.02K | $7.90M | New |
| Q3 2024 | 1.35M | $9.55M | New |
| Q4 2024 | 1.59M | $6.56M | Add |
| Q1 2025 | 10.83M | $28.37M | Add |
| Q2 2025 | 13.45M | $46.52M | Add |
| Q3 2025 | 14.77M | $77.12M | Add |
| Q4 2025 | 13.86M | $117.25M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RLAY
- Fidelity Management & Research (FMR) 20.11M sh · $376.26M · Q2 2026
- Casdin Capital 16.04M sh · $300.02M · Q2 2026
- BlackRock Inc 15.29M sh · $286.04M · Q2 2026
- Geode Capital Management 4.73M sh · $88.45M · Q2 2026
- Vanguard Group 9.69M sh · $81.99M · Q4 2025
- Morgan Stanley 3.85M sh · $72.05M · Q2 2026
- Goldman Sachs Group 3.41M sh · $63.78M · Q2 2026
- Bank of America Corp 2.70M sh · $50.43M · Q2 2026
- Arrowstreet Capital 2.24M sh · $41.89M · Q2 2026
- Northern Trust Corp 1.95M sh · $36.55M · Q2 2026
- Franklin Resources 1.86M sh · $34.74M · Q2 2026
- Charles Schwab Investment Management 1.50M sh · $28.08M · Q2 2026